Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.130
-0.020 (-1.74%)
At close: Sep 4, 2025, 4:00 PM
1.150
+0.020 (1.77%)
After-hours: Sep 4, 2025, 6:16 PM EDT
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $25.29 million as of September 4, 2025. Its market cap has decreased by -68.07% in one year.
Market Cap
25.29M
Enterprise Value
-52.34M
1-Year Change
-68.07%
Ranking
Category
Stock Price
$1.13
Market Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $25.29M, a decrease of -92.89%. That is a compound annual growth rate of -84.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 25.29M | -60.88% |
| Dec 31, 2024 | 64.67M | -81.83% |
| Mar 28, 2024 | 355.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.38B |
| Johnson & Johnson | 428.68B |
| AbbVie | 374.26B |
| UnitedHealth Group | 278.84B |
| AstraZeneca | 254.65B |
| Novo Nordisk | 253.55B |
| Novartis AG | 248.54B |
| Abbott Laboratories | 230.05B |